Page last updated: 2024-08-21

kainic acid and Hyperglycemia

kainic acid has been researched along with Hyperglycemia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jung, JS; Kim, CH; Kim, SJ; Kim, SS; Lim, SM; Park, SH; Sim, YB; Suh, HW1
Jung, JS; Kim, CH; Kim, SS; Lim, SM; Park, SH; Sharma, N; Sim, YB; Suh, HW1
Schauwecker, PE1
Bonhomme, N; Casara, P; Dorey, G; Lestage, P; Lockhart, B; Roger, A1

Other Studies

4 other study(ies) available for kainic acid and Hyperglycemia

ArticleYear
Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice.
    Brain research, 2014, May-20, Volume: 1564

    Topics: Animals; Blood Glucose; CA3 Region, Hippocampal; Cell Death; Glipizide; Glyburide; Hyperglycemia; Hypoglycemic Agents; Infusions, Intraventricular; Kainic Acid; Male; Mice; Mice, Inbred ICR; Neurons; Sulfonylurea Compounds; Tolbutamide

2014
Effect of pertussis and cholera toxins administered supraspinally on CA3 hippocampal neuronal cell death and the blood glucose level induced by kainic acid in mice.
    Neuroscience research, 2014, Volume: 89

    Topics: Animals; Blood Glucose; CA3 Region, Hippocampal; Cell Death; Cholera Toxin; Corticosterone; Hyperglycemia; Hypoglycemia; Infusions, Intraventricular; Insulin; Kainic Acid; Male; Mice; Mice, Inbred ICR; Neurons; Neuroprotective Agents; Pertussis Toxin; Seizures

2014
The effects of glycemic control on seizures and seizure-induced excitotoxic cell death.
    BMC neuroscience, 2012, Aug-06, Volume: 13

    Topics: Animals; Cell Count; Cell Death; Disease Models, Animal; Fasting; Glucose; Hippocampus; Hyperglycemia; Hypoglycemia; Insulin; Kainic Acid; Male; Mice; Mice, Inbred Strains; Neurotoxins; Phosphopyruvate Hydratase; Status Epilepticus; Streptozocin

2012
Protective effect of the antioxidant 6-ethoxy-2,2-pentamethylen-1,2-dihydroquinoline (S 33113) in models of cerebral neurodegeneration.
    European journal of pharmacology, 2001, Mar-23, Volume: 416, Issue:1-2

    Topics: Alloxan; Animals; Antioxidants; Body Temperature; Brain Ischemia; Cell Survival; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Hippocampus; Hyperglycemia; Injections, Intraventricular; Kainic Acid; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Nerve Degeneration; Neurons; Quinolines; Rats; Rats, Wistar; Rectum; Survival Rate; tert-Butylhydroperoxide

2001